Companies: 10,795·Total market cap: $144.5T
MediPharm Labs Corp.

MediPharm Labs Corp.

LABS.TOTSXHealthcare● Active
$0.08
+$0.01(+7.14%)
Market Cap$31864800
P/E Ratio
52W High$0.1
52W Low$0.06
Overview

MediPharm Labs Corp. (LABS.TO) · Balance Sheet

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · LABS.TO · as of 2026-06-10

Financial statements

Total Assets · Total Liabilities · Equity
Breakdown2025-122024-122023-122022-122021-12
Assets
Cash & ST Investments$10.81M$11.69M$17.98M$24.14M$34.11M
Net Receivables$7.53M$7.51M$5.87M$13.01M$16.92M
Inventory$8.02M$8.71M$9.90M$7.78M$10.98M
Total Current Assets$27.47M$33.08M$36.63M$47.34M$65.55M
PP&E Net$17.60M$19.16M$25.27M$18.11M$25.89M
Goodwill$0.00M$0.00M$0.00M$0.00M$0.00M
Intangible Assets$0.68M$0.85M$1.03M$0.04M$0.04M
Total Assets$45.74M$53.73M$63.94M$65.50M$92.36M
Liabilities
Short-Term Debt$0.15M$0.26M$2.10M$0.52M$0.00M
Accounts Payable$4.71M$4.24M$2.13M$3.54M$2.99M
Total Current Liabilities$9.93M$10.49M$10.86M$9.46M$8.88M
Long-Term Debt$0.00M$0.00M$0.00M$0.00M$0.00M
Total Liabilities$9.93M$10.55M$10.93M$9.49M$9.21M
Stockholders Equity
Retained Earnings($169.38M)($187.43M)($176.73M)($163.65M)($129.34M)
Total Stockholders Equity$35.81M$43.18M$53.01M$56.01M$83.15M
Total Liab & Equity(computed)$45.74M$53.73M$63.94M$65.50M$92.36M
Debt Summary
Total Debt$0.20M$0.39M$2.29M$0.63M$0.22M
Net Debt($10.61M)($11.30M)($15.69M)($23.51M)($33.89M)

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · CAD · M

Explore more MediPharm Labs Corp. data

About MediPharm Labs Corp. (LABS.TO) Balance Sheet

MediPharm Labs Corp. (LABS.TO) balance sheet shows total assets of $0.05B with cash of $0.01B. Total liabilities are $0.01B, total debt $0.00B, and stockholders equity $0.04B.

Frequently asked questions

LABS.TO · 4 questions

MediPharm Labs Corp. has total debt of $0.00B with net debt of ($0.01B).

LABS.TO total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10